Lance Alstodt — SPARQNOW

At-a-Glance

Chairman and CEO at BioRestorative Therapies, Inc.
Leads BioRestorative Therapies, focused on developing stem cell therapies for degenerative disc disease and metabolic disorders.
Oversees BRTX-100, an autologous stem cell product in a phase 2 clinical trial for chronic lumbar disc disease.
Manages the ThermoStem program, which uses brown adipose-derived stem cells.
Previously served as Managing Director at Bank Of America.
Held the position of Executive Director at Jpmorganchase.

Biography

Lance Alstodt is the Chairman and CEO of BioRestorative Therapies, Inc. The company is committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions, including degenerative disc disease and metabolic disorders.

Under his leadership, BioRestorative Therapies is advancing BRTX-100, an autologous stem cell product currently in a phase 2 clinical trial for chronic lumbar disc disease.